PREGABALIN HOVID (Hovid Australia Pty Ltd)
Product name
PREGABALIN HOVID
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
170 (255 working days)
Active ingredients
Pregabalin
Registration type
New generic medicine
Indication
PREGABALIN HOVID (pregabalin) is indicated for the treatment of neuropathic pain in adults.
PREGABALIN HOVID (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.